NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Liminatus Pharma, Inc. Class A Common Stock Share Price Chart

O H L

Liminatus Pharma, Inc. Class A Common Stock Performance Overview

Days Range
$3.41Low
$3.41High

Markets Today

Previous Close$3.39
Open$3.41
Volume8,873
Day's Range$3.41 - $3.41
52W RangeNA
Market Cap$4.47 M

Historical Performance

1M Returns-47.85
3M Returns-43.12
6M Returns-68.05
1Y Returns-94.74
5Y ReturnsNA
10Y ReturnsNA

Liminatus Pharma, Inc. Class A Common Stock Fundamentals

Market Cap$4.47 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A
Market Cap$4.47 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A

Liminatus Pharma, Inc. Class A Common Stock Return Calculator

The Liminatus Pharma, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.

FAQs

Liminatus Pharma, Inc. Class A Common Stock (LIMN) share price as of September 18, 2026 is $3.37. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Liminatus Pharma, Inc. Class A Common Stock (LIMN) Share by opening an international trading account with Angel One.
Purchasing Liminatus Pharma, Inc. Class A Common Stock (LIMN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Liminatus Pharma, Inc. Class A Common Stock (LIMN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Liminatus Pharma, Inc. Class A Common Stock (LIMN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Liminatus Pharma, Inc. Class A Common Stock on September 18, 2026, is $4.47 M.
Liminatus Pharma, Inc. Class A Common Stock operates in the null sector, specifically in the null industry.
In order to invest in Liminatus Pharma, Inc. Class A Common Stock (LIMN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91